See All Slides - tctmd.com

Slides

Presentation TCT 2013

How Would I Treat this Patient?(11)

Presenter: Kresimir Stambuk

October 31, 2013

Presentation TCT 2013

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

Presenter: David Erlinge

October 31, 2013

Presentation TCT 2013

Nothing But Doubt – The Data are Substandard and the Mechanisms Unclear!

Presenter: Gary Mintz

October 31, 2013

Presentation TCT 2013

Cases I and II: Serial Stenoses

Presenter: Pim Tonino

October 31, 2013

Presentation TCT 2013

Reinventing Yourself: How to Add New Procedures (Peripheral, Carotid, TAVR, Structural) to Your Practice

Presenter: Tony Das

October 31, 2013

Presentation TCT 2013

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Presenter: Michael Conte

October 31, 2013

Presentation TCT 2013

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Presenter: Edoardo Camenzind

October 31, 2013

Presentation TCT 2013

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Presenter: Chang-Wook Nam

October 31, 2013

Presentation TCT 2013

Progress in Women Undergoing Interventional Procedures: Is the Gap Narrowing?

Presenter: Alexandra Lansky

October 31, 2013

Advertisement

Slides

How Would I Treat this Patient?(11)

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

Nothing But Doubt – The Data are Substandard and the Mechanisms Unclear!

Cases I and II: Serial Stenoses

Reinventing Yourself: How to Add New Procedures (Peripheral, Carotid, TAVR, Structural) to Your Practice

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Progress in Women Undergoing Interventional Procedures: Is the Gap Narrowing?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content